A polymeric delivery vehicle, with neutral degradation products, keeps inflammation at bay during sustained drug release following myocardial infarction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sy, J. C. et al. Nature Mater. 7, 863–869 (2008).
Luman, N. R., Smeds, K. A. & Grinstaff, M. W. Chem. Eur. J. 9, 5618–5626 (2003).
Richards Grayson, A. C. et al. Nature Mater. 2, 767–772 (2003).
Tabata, Y., Gutta, S. & Langer, R. Pharm. Res. 10, 487–496 (1993).
Wang, C. et al. Nature Mater. 3, 190–196 (2004).
Zelikin, A. N., Zawaneh, P. N. & Putnam, D. Biomacromolecules 7, 3239–3244 (2006).
Zawaneh, P. N., Doody, A. M., Zelikin, A. N. & Putnam, D. Biomacromolecules 7, 3245–3251 (2006).
Heffernan, M. J. & Murthy, N. Bioconjug. Chem. 16, 1340–1342 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Putnam, D. The heart of the matter. Nature Mater 7, 836–837 (2008). https://doi.org/10.1038/nmat2309
Issue Date:
DOI: https://doi.org/10.1038/nmat2309